Epana Bio Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $11M

  • Investors
  • 13

Epana Bio General Information

Description

Developer of targeted therapeutic systems designed for autoimmune disease treatment. The company's platform integrates genomic analysis and artificial intelligence to identify and address the cellular origins of autoimmune disorders, supporting the discovery and development of precision medicines tailored to specific patient populations and enabling healthcare providers and patients in the autoimmune disease market to access therapies developed with a focused, data-driven approach aimed at improving treatment specificity and accelerating development timelines.

Contact Information

Website
www.epana.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 455 Market Street
  • Suite 1940 PMB 374183
  • San Francisco, CA 94105-2448
  • United States
Primary Industry
Drug Discovery
Other Industries
Decision/Risk Analysis
Vertical(s)
Artificial Intelligence & Machine Learning, HealthTech, Life Sciences
Corporate Office
  • 455 Market Street
  • Suite 1940 PMB 374183
  • San Francisco, CA 94105-2448
  • United States

Epana Bio Timeline

20252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Epana Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 01-Mar-2025 $11M Completed Generating Revenue
1. Seed Round 04-Dec-2024 Completed Generating Revenue
To view Epana Bio’s complete valuation and funding history, request access »

Epana Bio Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed-1
Seed-2
To view Epana Bio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Epana Bio Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
82VS Accelerator/Incubator Minority
Breakout Ventures Venture Capital Minority
Dimension (United States) Venture Capital Minority
Hawktail Venture Capital Minority
Hummingbird Ventures Venture Capital Minority
You’re viewing 5 of 13 investors. Get the full list »

Ready to get started?

Request a free trial

Epana Bio FAQs

  • When was Epana Bio founded?

    Epana Bio was founded in 2024.

  • Where is Epana Bio headquartered?

    Epana Bio is headquartered in San Francisco, CA.

  • What industry is Epana Bio in?

    Epana Bio’s primary industry is Drug Discovery.

  • Is Epana Bio a private or public company?

    Epana Bio is a Private company.

  • What is the current valuation of Epana Bio?

    The current valuation of Epana Bio is .

  • What is Epana Bio’s current revenue?

    The current revenue for Epana Bio is .

  • How much funding has Epana Bio raised over time?

    Epana Bio has raised $14M.

  • Who are Epana Bio’s investors?

    82VS, Breakout Ventures, Dimension (United States), Hawktail, and Hummingbird Ventures are 5 of 13 investors who have invested in Epana Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process